Tower Research Capital LLC (TRC) - UNICYCIVE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,638
-0.3%
3,068
+48.4%
0.00%
Q2 2023$2,646
+37700.0%
2,067
-39.5%
0.00%
Q1 2023$7
+133.3%
3,419
-31.6%
0.00%
Q4 2022$3
-99.9%
4,996
-3.5%
0.00%
Q3 2022$3,000
-25.0%
5,177
+0.2%
0.00%
Q2 2022$4,000
-20.0%
5,167
+34.5%
0.00%
Q1 2022$5,0003,8410.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nantahala Capital Management 647,416$828,6920.08%
Ground Swell Capital, LLC 40,002$51,2020.06%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$19,8400.01%
XTX Topco Ltd 14,461$18,5100.00%
Oxbow Advisors, LLC 11,861$15,1820.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,752$85,4420.00%
STATE STREET CORP 35,036$44,8460.00%
GOLDMAN SACHS GROUP INC 95,931$122,7920.00%
TWO SIGMA ADVISERS, LP 15,200$19,4560.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders